AGIOS PHARMACEUTICALS, INC.: cash_and_restricted_cash
| Value | {"amount": 127436000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | AGIOS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:11:26.786511+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2ce650c0-7127-43e6-9d72-02af51422dc2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001439222-21-000029Retrieved: 2026-08-19T14:11:26.786511+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001439222/cash-and-restricted-cash/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2ce650c0-7127-43e6-9d72-02af51422dc2
History
- no predecessors — first report